Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Measurement of hepatic venous pressure gradient in Liver cirrhosis: Relationship with the status of cirrhosis, varices, and ascites in Korea

Moon Young Kim, M.D., Soon Koo Baik, M.D., Ki Tae Suk, M.D., Change Jin Yea, M.D., Il Young Lee, M.D., Jae Woo Kim, M.D., Seung Hwan Cha, M.D. Young Ju Kim, M.D. Soon Ho Um, M.D. Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2008;14(2):150-158. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.150

View: 5594 Download: 95 Crossref: 20

Clinical Usefulness of ΔMELD to Predict the Survival of Patients with Liver Cirrhosis

Soo Hoon Eun, M.D., Yun Soo Kim, M.D. Jae Young Jang, M.D., Young Gook Cheon, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(4):530-538. Published online January 1, 1970

View: 2731 Download: 20

The Correlation of Child-Pugh Score, PGA Index and MELD Score in the Patient with Liver Cirrhosis and Hepatocellular Carcinoma According to the Cause of Alcohol and Hepatitis B Virus

Byoung Sik Mun , Heok Soo Ahn , Deuk Soo Ahn , Seung Ok Lee

Clin Mol Hepatol. 2003;9(2):107-115. Published online January 1, 1970

View: 2908 Download: 53

1 |

Viewed By 5401	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5366	MAFLD: How is it different from NAFLD?
Viewed By 5250	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3930	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3906	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search